Premier, Inc. Files 2025 Annual Report

TL;DR

PREM filed its 2025 10-K. All good.

AI Summary

Premier, Inc. filed its 10-K for the fiscal year ending June 30, 2025. The filing provides a comprehensive overview of the company's financial performance and business operations. Key financial data and disclosures are presented for the reporting period.

Why It Matters

This 10-K filing is crucial for investors and stakeholders to understand Premier, Inc.'s financial health, strategic direction, and potential risks for the fiscal year 2025.

Risk Assessment

Risk Level: low — The filing is a standard annual report and does not indicate any immediate or unusual risks.

Key Numbers

• 20250630 — Fiscal Year End (The end date of the reporting period for the 10-K.)
• 20250819 — Filing Date (The date Premier, Inc. submitted this 10-K to the SEC.)

Key Players & Entities

• Premier, Inc. (company) — Filer of the 10-K
• 20250630 (date) — Fiscal year end date
• 20250819 (date) — Filing date
• 704-357-0022 (phone_number) — Company business phone

FAQ

Key Financial Figures

• $0.01 — which registered Class A Common Stock, $0.01 Par Value PINC NASDAQ Global Select Mar
• $12.8 million — directly tied to the S2S Divestiture of $12.8 million in continuing operations. With the $52.
• $52.6 million — lion in continuing operations. With the $52.6 million loss in discontinued operations, the ne
• $39.8 million — act associated with the divestiture was $39.8 million. We met the criteria for classifying ce
• $15.0 m — etwork business for a purchase price of $15.0 million, subject to working capital and o
• $13.9 million — these certain assets and liabilities of $13.9 million. We continue to own and operate Contigo
• $1.0 billion — tors authorized the repurchase of up to $1.0 billion of our outstanding Class A common stock
• $400.0 million — America") to repurchase an aggregate of $400.0 million of shares of our Common Stock, which wa
• $200.0 million — Directors approved execution of another $200.0 million of Common Stock repurchases under the S
• $800 million — er the authorization in addition to the $800 million of repurchases described above. Refer t
• $47.5 m — preliminary adjusted purchase price of $47.5 million, net of cash acquired, and subjec
• $4.5 million — on hand, net of cash acquired, of which $4.5 million was placed in escrow to secure primaril
• $15.0 — o the former IllumiCare owners of up to $15.0

Filing Documents

• pinc-20250630.htm (10-K) — 2585KB
• ex1033-pincxfy25x0630.htm (EX-10.33) — 9KB
• ex191-pincxfy25x0630.htm (EX-19.1) — 44KB
• ex192-pincxfy25x0630.htm (EX-19.2) — 33KB
• ex21-pincxfy25x0630.htm (EX-21) — 18KB
• ex23-pincxfy25x0630.htm (EX-23) — 5KB
• ex311-pincxfy25x0630.htm (EX-31.1) — 11KB
• ex312-pincxfy25x0630.htm (EX-31.2) — 11KB
• ex321-pincxfy25x0630.htm (EX-32.1) — 6KB
• ex322-pincxfy25x0630.htm (EX-32.2) — 6KB
• ex97-pincxfy25x0630.htm (EX-97) — 21KB
• pinc-20250630_g1.jpg (GRAPHIC) — 126KB
• 0001577916-25-000011.txt ( ) — 13784KB
• pinc-20250630.xsd (EX-101.SCH) — 79KB
• pinc-20250630_cal.xml (EX-101.CAL) — 137KB
• pinc-20250630_def.xml (EX-101.DEF) — 541KB
• pinc-20250630_lab.xml (EX-101.LAB) — 1010KB
• pinc-20250630_pre.xml (EX-101.PRE) — 805KB
• pinc-20250630_htm.xml (XML) — 1977KB

RISK FACTORS

ITEM 1A. RISK FACTORS 22

UNRESOLVED STAFF COMMENTS

ITEM 1B. UNRESOLVED STAFF COMMENTS 49 ITEM 1C. CYBERSECURITY 49

PROPERTIES

ITEM 2. PROPERTIES 50

LEGAL PROCEEDINGS

ITEM 3. LEGAL PROCEEDINGS 51

MINE SAFETY DISCLOSURES

ITEM 4. MINE SAFETY DISCLOSURES 51 PART II

MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 52

RESERVED

ITEM 6. RESERVED 53

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 54

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 79

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 80

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 121

CONTROLS AND PROCEDURES

ITEM 9A. CONTROLS AND PROCEDURES 121

OTHER INFORMATION

ITEM 9B. OTHER INFORMATION 121

DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 122 PART III

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 123

EXECUTIVE COMPENSATION

ITEM 11. EXECUTIVE COMPENSATION 123

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 123

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 124

PRINCIPAL ACCOUNTING FEES AND SERVICES

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES 124 PART IV

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES 125

FORM 10-K SUMMARY

ITEM 16. FORM 10-K SUMMARY 128

SIGNATURES

SIGNATURES 129 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS competition which could limit our ability to maintain or expand market share within our industry; our reliance on administrative fees that we receive from suppliers to our group purchasing organization ("GPO") and our ability to maintain and add new GPO members, which will depend in part on competitive pressure to increase the administrative fee share we pay to members; consolidation in the healthcare industry; potential delays in recognizing or increasing revenue if the sales cycle or implementation p

Business

Item 1. Business The following discussion should be read in conjunction with our consolidated financial statements and accompanying notes thereto included elsewhere in this Annual Report on Form 10-K. The following discussion includes certain forward-looking statements. For a discussion of important factors which could cause actual results to differ materially from the results referred to in the historical information and the forward-looking statements presented herein, see "Item 1A. Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" contained in this Annual Report. Our Company Premier, Inc. ("Premier," the "Company," "we," "us," or "our"), a publicly held, for-profit corporation, incorporated in Delaware on May 14, 2013, is a leading technology-driven healthcare improvement company, providing solutions to healthcare providers in the United States. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers, and payers to make healthcare better with national scale, smarter with actionable intelligence and faster with novel technologies. Premier offers integrated data and analytics, collaboratives, supply chain solutions, consulting and other services in service of our mission to improve the health of communities. We partner with hospitals, health systems, physicians, employers, product suppliers, service providers, and other healthcare providers and organizations with the common goal of improving and innovating in the clinical, financial, and operational areas of their businesses to meet the demands of a rapidly evolving healthcare industry, and we continue to expand our capabilities to more fully address and coordinate care improvement and standardization in the payer, and life sciences markets. With integrated data and analytics, collaboratives, supply chain services, consulting, and other services, Premier enables healthcare providers to deliver better care and outcomes at a lower cost. We beli

View Full Filing

View this 10-K filing on SEC EDGAR